Johnson & Johnson Medical Devices drops ‘medical devices’ in rebranding

Johnson & Johnson Medical Devices has rebranded as Johnson & Johnson MedTech as the unit moves deeper into digital technology.

New Brunswick, New Jersey-based Johnson & Johnson (NYSE: JNJ) noted the coming change in its 2022 annual report published last month, saying the switch would take effect in the company’s first fiscal quarter.

That preview was followed by a March 7 announcement of approximately 100 words, mostly attributed to Johnson & Johnson MedTech EVP and Executive Chair Ashley McEvoy.

“Our business sits at the compelling intersection of medical devices and medical technology, and as the world’s most broadly based medtech company, we are committed to delivering breakthrough scientific innovation and reimagining health in an increasingly digital world,” McEvoy said. “As we continue to innovate for the future, it’s important that our new sector identity reflects our global leadership as a medtech innovator positively impacting the health of millions of patients around the world.”

Johnson & Johnson provided more information to Medical Design & Outsourcing today, saying the “new Johnson & Johnson MedTech identity reflects our commitment to delivering breakthrough scientific innovation and reimagining health in an increasingly digital world. As the most broadly based medtech business in the world, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to empower everyone to live their best life possible. At Johnson & Johnson MedTech, we go beyond what’s next to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized.”

That sounds an awful lot like what Medical Devices — I mean, MedTech — Group CIO and Global VP Larry Jones and Office of Digital Innovation Leader Peter Schulam had to say about the future of the company and the medtech industry when I spoke with them recently about the power of the cloud in the wake of Johnson & Johnson’s deal with Microsoft (Nasdaq: MSFT).

Johnson & Johnson is the second-largest medtech company in the world, according to Medical Design & Outsourcing‘s latest Medtech Big 100 ranking.

The Johnson & Johnson MedTech segment covers interventional solutions, orthopedics, surgery and vision, with brand names such as Biosense Webster, Cerenovus, DePuy Synthes, Ethicon, Acclarent and Acuvue.